Business
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx’s legal, compliance, regulatory, and government affairs operations
About this update from Ardelyx, Inc.
[{"type":"image","alt":"Ardelyx, Inc.","displaySize":"","headline":null,"caption":"Ardelyx, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":69,"url":"https://media.zenfs.com/en/globenewswire.com/a298be5d2f697490ef96d120079c7c36"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RM55PLkwIm0i9lblgEqDyQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk3/https://media.zenfs.com/en/globenewswire.com/a298be5d2f697490ef96d120079c7c36","width":300,"height":69}},"lazy":false},{"type":"text","content":"WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx’s legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company.","length":622,"tagName":"p"},{"type":"text","content":""I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mike Raab, President and Chief Executive Officer of Ardelyx. "Her deep and thoughtful strategic legal leadership strengthens our ability to execute and accelerate value creation for our shareholders. As we continue to build upon our commercial foundation and invest in our pipeline, Felecia’s proven skill navigating complex regulatory environments and partnering across the business will be critical. We are confident she will play a key role in advancing our growth strategy while staying true to our commitment to patients."","length":619,"tagName":"p"},{"type":"text","content":"“It is truly an exciting time to join Ardelyx, as the company faces meaningful growth and evolution,” said Ms. Ettenberg. “I look forward to collaborating closely with colleagues across the organization to provide thoughtful, practical legal guidance that enables teams to move forward with confidence, navigate a dynamic policy environment, and execute on strategic priorities. Ardelyx’s mission, vision, and dedication to patients strongly align with my passion for helping patients, and I’m very excited by the...